Senvest Management LLC Acquires 48,800 Shares of American Well Co. (NYSE:AMWL)

Senvest Management LLC grew its holdings in shares of American Well Co. (NYSE:AMWL) by 3.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,300,611 shares of the company’s stock after buying an additional 48,800 shares during the quarter. Senvest Management LLC owned approximately 8.49% of American Well worth $9,429,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of AMWL. Takeda Pharmaceutical Co. Ltd. bought a new stake in American Well during the fourth quarter worth about $564,000. HighTower Advisors LLC bought a new position in shares of American Well in the third quarter valued at $355,000. Norges Bank acquired a new position in American Well during the fourth quarter worth $204,000. BNP Paribas Financial Markets bought a new stake in American Well during the third quarter worth $95,000. Finally, Compagnie Lombard Odier SCmA acquired a new stake in American Well in the fourth quarter valued at $45,000. 56.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on AMWL shares. Needham & Company LLC reaffirmed a “hold” rating on shares of American Well in a report on Thursday, February 13th. Truist Financial cut their price objective on American Well from $12.00 to $7.50 and set a “hold” rating for the company in a research report on Thursday. Morgan Stanley decreased their target price on American Well from $20.00 to $10.50 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Stifel Nicolaus raised their price target on American Well from $9.00 to $10.00 and gave the company a “hold” rating in a report on Thursday, February 13th. Finally, Wells Fargo & Company upgraded shares of American Well from an “equal weight” rating to an “overweight” rating and set a $15.00 price objective on the stock in a report on Monday, January 13th. Five equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, American Well presently has an average rating of “Hold” and a consensus price target of $11.00.

American Well Trading Down 2.5 %

NYSE:AMWL opened at $7.07 on Monday. The stock has a 50 day simple moving average of $9.01 and a 200 day simple moving average of $9.08. American Well Co. has a 1-year low of $5.00 and a 1-year high of $12.95. The stock has a market cap of $110.36 million, a P/E ratio of -0.51 and a beta of 1.22.

American Well (NYSE:AMWL) last issued its quarterly earnings data on Wednesday, February 12th. The company reported ($2.77) earnings per share for the quarter, topping the consensus estimate of ($3.04) by $0.27. American Well had a negative net margin of 81.83% and a negative return on equity of 56.73%. As a group, sell-side analysts forecast that American Well Co. will post -9.34 EPS for the current year.

Insiders Place Their Bets

In other American Well news, insider Phyllis Gotlib sold 4,781 shares of the firm’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $8.80, for a total value of $42,072.80. Following the transaction, the insider now directly owns 147,998 shares of the company’s stock, valued at $1,302,382.40. This trade represents a 3.13 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold a total of 5,219 shares of company stock worth $46,454 in the last 90 days. Company insiders own 12.80% of the company’s stock.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.